Investors who lost money on Merck & Co., Inc. (MRK) should contact Levi & Korsinsky about pending Class Action - MRK
Portfolio Pulse from
A class action securities lawsuit has been filed against Merck & Co. alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 26, 2025 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock price dropped over 9% following announcement of Gardasil shipment cessation in China and potential misrepresentation of sales forecasts.
The lawsuit alleges Merck misled investors about Gardasil sales potential, which could result in financial penalties and damage to investor confidence.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100